跳至主要内容
临床试验/NCT00290082
NCT00290082终止3 期

Comparison Between Midazolam and Loxapine in the Treatment of Agitated Patients in the Emergency Department

University Hospital, Rouen2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2005年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
120
试验地点
2
主要终点
Success of treatment at 20 min

研究概览

简要总结

Neuroleptics are used since a long time in the management of severely agitated patients. Loxapine is routinely used in our country, with, to our knowledge no severe adverse event reported, in this indication.

However, recently, benzodiazepines have appeared interesting in agitated patients, with the use of midazolam.

The aim of this study is to compare midazolam to loxapine in the treatment of severe agitated patients admitted in the emergency department.

详细描述

Prospective, Randomized, Double-blind, Multicenter study (20 french emergency departments)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Severely agitated patients (Richard Scale over or equal to 5) between 18 and 65 years old

排除标准

  • Hypoglycemia hypoxemia patients with known dementia blood pressure <90 mmHg known cocaine or amphetamine intoxication pregnancy respiratory or liver insufficiency myasthenia sedation before arrival to hospital

研究组 & 干预措施

loxapine

Active Comparator

agitated patients were randomly assigned either to loxapine, either to midazolam group

干预措施: loxapine, midazolam (Drug)

loxapine

Active Comparator

agitated patients were randomly assigned either to loxapine, either to midazolam group

干预措施: blood sample (Biological)

loxapine

Active Comparator

agitated patients were randomly assigned either to loxapine, either to midazolam group

干预措施: patient monitoring (Other)

loxapine

Active Comparator

agitated patients were randomly assigned either to loxapine, either to midazolam group

干预措施: Loxapine (Drug)

midazolam

Active Comparator

midazolam is compared to loxapine in terms of efficacy and tolerance

干预措施: loxapine, midazolam (Drug)

midazolam

Active Comparator

midazolam is compared to loxapine in terms of efficacy and tolerance

干预措施: blood sample (Biological)

midazolam

Active Comparator

midazolam is compared to loxapine in terms of efficacy and tolerance

干预措施: patient monitoring (Other)

midazolam

Active Comparator

midazolam is compared to loxapine in terms of efficacy and tolerance

干预措施: Midazolam (Drug)

结局指标

主要结局

Success of treatment at 20 min

时间窗: 20 min

次要结局

  • Sedation duration
  • Need for rescue medication(any time)
  • Success of treatment at 40 and 60 min(40 and 60 mn)
  • Agitation level at 20,40 and 60 min(20, 40 and 60mn)
  • treatment failure(one hour after treatment)

研究者

发起方
University Hospital, Rouen
申办方类型
Other

研究点 (2)

Loading locations...

相似试验